| RS397989794 |
GFI1B
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 17, Platelet-type bleeding disorder 17 |
| RS398122360 |
HOXA2
|
Health Risk |
Pathogenic |
MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT |
| RS398122361 |
DSE
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS398122363 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS398122364 |
CARD9
|
Health Risk |
risk factor |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS398122365 |
MTRFR
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 55, Hereditary spastic paraplegia 55 |
| RS398122366 |
TTI2
|
Health Risk |
Pathogenic |
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, Inborn genetic diseases |
| RS398122367 |
TTI2
|
Health Risk |
Pathogenic |
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome |
| RS398122368 |
SMARCB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS398122369 |
TUBB2B
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 7, Lissencephaly |
| RS398122370 |
PRNP
|
Health Risk |
Pathogenic |
Inherited Creutzfeldt-Jakob disease, Inherited Creutzfeldt-Jakob disease |
| RS398122372 |
ITGB3
|
Health Risk |
Pathogenic |
Bleeding disorder, platelet-type |
| RS398122373 |
ITGB3
|
Health Risk |
Pathogenic |
Bleeding disorder, platelet-type |
| RS398122375 |
PRRX1
|
Health Risk |
Pathogenic |
Agnathia-otocephaly complex, Agnathia-otocephaly complex |
| RS398122377 |
HOXC13
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 9, hair/nail type |
| RS398122378 |
MIP
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 15 multiple types, MIP-related disorder |
| RS398122379 |
HK1
|
Health Risk |
Pathogenic |
Hemolytic anemia due to hexokinase deficiency, Hemolytic anemia due to hexokinase deficiency |
| RS398122380 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS398122381 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS398122382 |
B4GALNT1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 26, Spastic paraplegia |
| RS398122383 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 105, Immunodeficiency 105 |
| RS398122384 |
PIK3R1
|
Health Risk |
Pathogenic |
SHORT syndrome, SHORT syndrome |
| RS398122385 |
PIK3R1
|
Health Risk |
Pathogenic |
SHORT syndrome, SHORT syndrome |
| RS398122386 |
POLD1
|
Health Risk |
Pathogenic |
Mandibular hypoplasia-deafness-progeroid syndrome, Hereditary cancer-predisposing syndrome |
| RS398122387 |
CNTN2
|
Health Risk |
Pathogenic |
Epilepsy, familial adult myoclonic |
| RS398122388 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS398122389 |
RPSA
|
Health Risk |
Pathogenic |
Familial isolated congenital asplenia, Familial isolated congenital asplenia |
| RS398122390 |
HDAC6
|
Health Risk |
Pathogenic |
X-linked dominant chondrodysplasia, Chassaing-Lacombe type |
| RS398122391 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Retinitis pigmentosa |
| RS398122392 |
CRYGC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 2, multiple types |
| RS398122393 |
TAC3
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 10 with or without anosmia, Hypogonadotropic hypogonadism 10 with or without anosmia |
| RS398122394 |
ALG13
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 36 |
| RS398122395 |
SLC20A2
|
Health Risk |
Pathogenic |
SLC20A2-related disorder, Idiopathic basal ganglia calcification 1 |
| RS398122396 |
SLC20A2
|
Health Risk |
Pathogenic |
SLC20A2-related disorder, Idiopathic basal ganglia calcification 1 |
| RS398122397 |
SLC20A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS398122398 |
PDGFB
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS398122399 |
PDGFB
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS398122400 |
DSG1
|
Health Risk |
Pathogenic |
Severe dermatitis-multiple allergies-metabolic wasting syndrome, Severe dermatitis-multiple allergies-metabolic wasting syndrome |
| RS398122401 |
CFAP298
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 26, Primary ciliary dyskinesia 26 |
| RS398122402 |
GATA4
|
Health Risk |
Pathogenic |
Testicular anomalies with or without congenital heart disease, Testicular anomalies with or without congenital heart disease |
| RS398122403 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS398122404 |
DNAJC6
|
Health Risk |
Pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome |
| RS398122405 |
DNAJC6
|
Health Risk |
Pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile onset Parkinson disease 19A |
| RS398122406 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS398122407 |
VPS33B
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis, renal dysfunction |
| RS398122408 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS398122409 |
C19orf12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation |
| RS398122410 |
ERMARD
|
Health Risk |
Pathogenic |
Periventricular nodular heterotopia 6, Periventricular nodular heterotopia 6 |
| RS398122412 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS398122414 |
PRNP
|
Health Risk |
Likely pathogenic |
CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED |
| RS398122415 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS398122416 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS398122417 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS398122418 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS398122419 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS398122513 |
BAX
|
Health Risk |
Pathogenic |
T-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia |
| RS398122514 |
FLT3
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS398122515 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome, Hereditary cancer-predisposing syndrome |
| RS398122516 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS398122517 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS398122518 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS398122519 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS398122520 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS398122521 |
FLNA
|
Health Risk |
Pathogenic |
CONGENITAL SHORT BOWEL SYNDROME, X-LINKED |
| RS398122522 |
PRLR
|
Health Risk |
Pathogenic |
Familial hyperprolactinemia, Familial hyperprolactinemia |
| RS398122523 |
ARFGEF2
|
Health Risk |
Pathogenic |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS398122524 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS398122525 |
RHO
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS398122527 |
DLX5
|
Health Risk |
Pathogenic |
Split hand-foot malformation 1, Split hand-foot malformation 1 |
| RS398122528 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122530 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS398122531 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122532 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122533 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122534 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122535 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122536 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122538 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122539 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122541 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122542 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122544 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122545 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122546 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122547 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122548 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122549 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122550 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122551 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122552 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS398122554 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122555 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122556 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122557 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122558 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122559 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS398122560 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122561 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122564 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS398122565 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |